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LYMPH SCROTUM: AN UNUSUAL UROLOGICAL PRESENTATION OF LYMPHATIC FILARIASIS.  
A CASE SERIES STUDY
Ana Maria AGUIAR-SANTOS(1), Marcela LEAL-CRUZ(1), Maria José NETTO(1), Arturo CARRERA(1), Guilherme LIMA(2) & Abraham ROCHA(1)
SUMMARY
Lymphatic filariasis (LF) causes a wide range of clinical signs and symptoms, including urogenital manifestations. Transmission 
control and disability/morbidity management/control are the two pillars of the overall elimination strategy for LF. Lymph scrotum 
is an unusual urological clinical presentation of LF with important medical, psychological, social and economic repercussions. A 
retrospective case series study was conducted on outpatients attended at the National Reference Service for Filariasis, in an endemic 
area for filariasis (Recife, Brazil), between 2000 and 2007. Over this period, 6,361 patients were attended and seven cases with lymph 
scrotum were identified. Mean patient age was 45 years (range, 26 to 64 years). Mean disease duration was 8.5 years (range, two 
to 15 years). All patients had evidence of filarial infection from at least one laboratory test (parasitological, antigen investigation or 
“filarial dance sign” on ultrasound). Six patients presented histories of urological surgery. The authors highlight the importance of the 
association between filarial infection and the inadequate surgical and clinical management of hydrocele in an endemic area, as risk 
factors for lymph scrotum. Thus, filarial infection should be routinely investigated in all individuals presenting urological morbidity 
within endemic areas, in order to identify likely links in the transmission chain.
KEYWORDS: Lymph scrotum; Lymphatic filariasis; Morbidity control; Scrotal lesion; Wuchereria bancrofti.
INTRODUCTION
Lymphatic filariasis (LF) is a vector-borne parasitic disease caused 
by three lymphatic-dwelling nematode parasites, namely Wuchereria 
bancrofti, Brugia malayi and B. timori9. LF is one of the leading causes 
of permanent and long-term disability in the world and has been targeted 
for elimination by an important task force24,30,34 . 
The World Health Organization estimates that close to 20% of 
the world’s population is living at risk of the disease, which affects 
120 million people in at least 83 countries throughout the tropics and 
subtropics33. More than 40 million people suffer from chronic forms of 
the disease (lymphedema, elephantiasis or hydrocele) caused by these 
nematodes31, and approximately 29 million men worldwide present 
urogenital manifestations of lymphatic filariasis3,26. Wuchereria bancrofti 
is the only lymphatic filarial parasite that induces genital diseases11.
Filariasis is an important cause of disability, both because of its social 
stigma and because of psychosocial damage and economic losses31. It 
is believed that around 15 to 20% of infected individuals may evolve 
to clinical filarial disease14. In Brazil, it is estimated that three million 
individuals live in areas considered to be at risk and approximately 
49,000 people are infected with W. bancrofti. The largest sample is in the 
metropolitan area of Recife, in the northeastern region4,8,19,20,21.
Lymph scrotum or superficial scrotal lymphangiomatosis is a urogenital 
condition characterized by the presence of lymphatic vesicles on the surface 
of the scrotal skin that can easily rupture, giving rise to drainage of the 
whitish secretion typical of the disease (Fig. 1). This secretion serves as 
an excellent culturing medium that favors repeated bacterial infections. 
It may trigger progression of the condition to lymphedema and scrotal 
elephantiasis, the advanced stages of the disease7,11,15.
The pathogenesis of the clinical forms caused by adult worms is 
known, with lymphangiectasia as the turning point in the natural history 
of the disease. However, the pathogenesis of lymph scrotum is not well 
defined15,17. There is scarce information in the literature about this morbid 
condition. Although lymph scrotum is a less frequent manifestation of LF, 
it has important medical, psychological and socioeconomic repercussions 
for individuals who present this condition. It seems to be the complication 
of LF that produces the greatest incapacitation among men11. 
The aim of the present study was to provide support for diagnosis and 
therapeutic management of this chronic genital morbid condition and to 
draw attention to the clinical and surgical approaches towards hydrocele 
among patients living in an endemic area.
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MATERIAL AND METHODS
The National Reference Service for Filariasis (CPqAM/FIOCRUZ) 
in Recife, Pernambuco State (Brazil) is an outpatient clinic that provides 
care for individuals who have been identified and referred through 
research projects coordinated by this clinic. It also provides care for 
patients referred from various public or private clinics for investigations 
on filarial disease. A survey was conducted on the medical records of all 
patients attended between 2000 and 2007 and seven men with a diagnosis 
of lymph scrotum on admission were identified. These seven cases were 
admitted between April 2002 and April 2005. 
Over the study period, 6,361 patients were attended, of whom 4,280 
(67.2%) were male. All the patients were from the metropolitan region of 
Recife, which is an endemic area for this disease. The Research Ethics 
Committee of CPqAM (CEP/CPqAM/FIOCRUZ) gave its approval for 
this study (CAAE: 0061.0.095.000-07).
All the patients included in this study underwent clinical and 
urological assessments and laboratory evaluations. The parasitological 
diagnosis was performed using the technique of filtration on a 
polycarbonate membrane to investigate microfilariae in nocturnal blood 
samples (thereby respecting the local periodicity of the microfilariae)10. 
The serological diagnosis was performed using the antigen investigation 
techniques of ELISA (Enzyme-Linked Immunosorbent Assay) Og4C322 
and ICT-AD12 (Immunochromatographic Test)29. 
In addition, scrotal ultrasonography was performed by radiologists 
with extensive experience in identifying the “filarial dance sign”, which 
consists of movements suggestive of the presence of adult filarial worms 
of W. bancrofti in the lymphatic vessels5, as well as to identify other 
possible urological abnormalities.
The patients received guidance regarding genital hygiene, which is a 
measure of major importance for managing filarial morbidity. In case of 
successive acute crises, antibiotic prophylaxis with benzathine penicillin 
was also used to better control the condition. The patients with positive 
parasitological tests (microfilaremia) and/or the “filarial dance sign” on 
ultrasound examination were treated with diethylcarbamazine (DEC), 
according the WHO recommendations (6 mg/kg/day for 12 days).
RESULTS
Seven patients of ages ranging from 26 to 64 years were identified 
as presenting lymph scrotum. All of them came from urban areas in 
the metropolitan region of Recife that were recognized to be endemic 
for Bancroftian filariasis: the cities of Recife, Olinda and Jaboatão dos 
Guararapes.
The time that had elapsed between the initial clinical manifestations 
(scrotal pain, increased scrotal volume and localized signs of 
inflammation) and the diagnosis ranged from two to 15 years. Among 
the seven patients, five presented previous histories of filarial infection 
(positive result from the thick smear test at a time prior to the diagnosis 
of the present study) and only two of these had undergone previous 
treatment with DEC. All of the patients reported recurrent episodes of 
acute dermal lymphangioadenitis.
Through complementary investigations, at least one characteristic 
relating to the etiology of filariasis could be shown in all the patients. 
Five patients presented microfilaremia. Of these five, only one presented 
microfilaremia alone; three presented microfilaremia and tested positive 
for antigens (Og4C3 and ICT), while one had microfilaremia, antigenemia 
positive for Og4C3 and adult Wuchereria bancrofti worms (“filarial dance 
sign” on scrotal ultrasonography). One patient with adult filarial worms 
who was negative for microfilariae was also serologically positive using 
the ICT and ELISA Og4C3 techniques. One patient was only positive 
for Og4C3 (Table 1).
Among the associated findings detected by means of scrotal 
ultrasonography and/or urological examination, the following are 
described in Table 2: lymphangiectasia (n = 5), hydrocele (n = 3), 
varicocele (n = 2), nodules in the scrotal region (n = 3), testicular 
abnormalities (n = 2), epididymal abnormalities (n = 2), adenopathy 
(n = 1) corresponding to bilateral inguinal adenomegaly and scrotal 
lymphangitis (n = 1). The following epididymal and testicular 
abnormalities were found: textural abnormalities seen on ultrasound, 
presence of calcifications, increased or decreased testicular volume and 
presence of a cyst in the head of the epididymis.
Six of the seven patients had undergone some type of urological 
treatment prior to the appearance of lymph scrotum, but none of them had 
been followed up from a urological point of view prior to their admission 
to the National Reference Service, to detect late complications. All of 
these six patients had undergone hydrocelectomy. Among these six, two 
had undergone another surgical procedure in addition to hydrocelectomy, 
one had undergone hernioplasty and one had had surgery to remove a 
nodule from inside the scrotum. Among the three patients who presented 
nodules in the scrotum on urological examination, two had already 
undergone treatment with DEC.
With regard to the orientation of the surgical incision among the 
six patients with previous hydrocelectomy, three underwent transversal 
incisions and two had longitudinal incisions (one unilaterally and the 
other bilaterally), while in one case the orientation was unknown. 
Fig. 1 - Lymph scrotum showing the presence of vesicles forming the site for lymphatic 
drainage.
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DISCUSSION
Lymph scrotum almost always occurs in patients with a previous 
history of acute episodes of filariasis that are characterized by 
lymphangitis due to bacterial and/or fungal infection, and who present 
chronic lymphangiectasia13,27. This condition may be identified following 
surgery for chylocele or hydrocele and it is a dermatological manifestation 
of pathological lymphatic drainage11. Its prevalence in endemic areas is 
unknown: only isolated cases have been reported in the literature1,3,7.
The occurrence of acute episodes of dermal lymphangioadenitis 
due to secondary bacterial infection in lymphatic vessels that are more 
superficial is the greatest risk factor for the appearance of lymph scrotum11. 
The presence of lymphangiectasia, which is the preponderant factor in the 
appearance of other clinical presentations of filariasis, was not observed 
in all of the seven individuals enrolled in this study. Nevertheless, before 
deeming that the presence of lymphangiectasia is not a factor required 
for lymph scrotum to appear, the technical difficulty in investigating this 
anatomopathological substrate needs to be taken into account.
The pathogenesis of lymph scrotum is still not fully defined15,17. 
ACTON & RAO1 suggested that the appearance of this condition was 
associated with previous surgery for hydrocele. The surgical technique 
appears to be an important factor. Although surgeons have recommended 
partial excision of the sac by means of “bottle neck” inversion of 
the tunica vaginalis, current thinking is that complete excision with 
meticulous attention to cauterization of the edges and oversuturing 
offers the best cosmetic and functional result, with less risk of lymph 
scrotum11,32. Furthermore, the orientation of the scrotal incision seems 
to have some importance in the appearance of lymph scrotum. Some 
urologists have chosen to make a transversal incision in the scrotum for 
esthetic reasons. However, particularly in cases of hydrocele secondary to 
urogenital filariasis, other surgeons have made the incision longitudinally 
to avoid sectioning the superficial lymphatic vessels in the skin and 
subcutaneous tissue, thereby preventing predisposition towards lymph 
scrotum11. 
Despite the small number of cases evaluated, the data from the present 
study suggest that the transversal orientation for the surgical incision may 
contribute as a predisposing factor towards establishing lymph scrotum. 
Nonetheless, the transversal orientation should not be defined as the 
only causal or predisposing factor for lymph scrotum, since two patients 
who underwent longitudinal incisions, and even one patient without any 
history of surgery, developed lymph scrotum over the course of their 
filarial disease. In view of the possibility of late complications such as 
lymph scrotum or genital lymphedema, patients with hydrocele from 
endemic areas for LF who have undergone surgery should have clinical 
follow-up. It needs to be borne in mind that there is no “simple hydrocele” 
Table 1
Laboratory results from investigations on the etiology of filariasis in seven patients with lymph scrotum. CPqAM, 2000-2007
Patient Age




ELISA Og4C3 ICT-AD12 Ultrasound
1 28 + + + -
2 41 + - - -
3 26 - + - -
4 64 + + + -
5 33 + + - +
6 36 + + + -
7 55 - + + +
Table 2
Clinical and/or ultrasound findings from patients with lymph scrotum. CPqAM, 2000-2007 
Ultrasound findings / urological evaluation
Patients
1 2 3 4 5 6 7
Lymphangiectasia + - + + - + +
Hydrocele + - + - - - +
Varicocele - - + - - - +
Nodule inside scrotum - - + + - + -
Adenopathy - - - - - + -
Lymphangitis - - - - - - +
Testicular abnormality + - + - - - -
Epididymal abnormality - - + - - - +
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in patients living in endemic areas. Prophylaxis and adequate treatment 
for episodes of acute dermal lymphangioadenitis in damaged lymphatic 
systems are essential for reducing the risk factors for lymph scrotum.
The repercussions of lymph scrotum for our patients were dramatic. 
The constant crises caused by repeated infections with continual drainage 
of milky secretion prevent them from carrying out their work or leisure 
activities, and may even have harmed their social interactions. In order to 
carry out their routine activities, some patients used inventive precautions 
such as covering the scrotal region with plastic, toilet paper or cloth. At the 
times of their crises, these patients also complained that it was impossible 
to have sexual intercourse. Moreover, the repeated infections could evolve 
into a condition of scrotal elephantiasis. All these circumstances together 
caused psychological stress that could lead these patients to depression. 
With regard to the clinical evolution of the disease, it was observed 
that this took place over a long period ranging from two to 15 years. Thus, 
this presentation was characterized as chronic, just like lymphedema3. 
Among the five patients with a previous history of filariasis, only two 
had undergone treatment with DEC. The importance of the treatment in 
these patients is reflected in two ways. Firstly, at the individual level, lack 
of treatment for individuals with microfilaremia may have an influence 
on the time taken for the disease to evolve and thus make it possible for 
greater morbidity to occur. Secondly, it brings out a particular feature 
observed in relation to the disease transmission chain. This concerns the 
finding that five patients presented filarial morbidity and microfilaremia. 
In clinical practice, it has commonly been observed that patients with 
chronic disease do not present microfilaremia5,12,28. However, even 
knowing that the group of patients with chronic manifestations of 
filariasis is not the principal source involved in the transmission chain, 
this possibility cannot be ignored. Thus, treatment for these individuals 
when they present microfilaremia may be of fundamental importance for 
controlling transmission. Furthermore, it is important to highlight the fact 
that these individuals continue to live in endemic areas, with the risk of 
reinfection. Therefore, they must be included within the local filariasis 
control program, either in mass drug treatment or in routine individual 
investigation. Since DEC must not be given because of potential side 
effects during coinfection with onchocerciasis, the recommended 
treatment in these regions is a single dose of ivermectin and albendazole18. 
It has been recognized in endemic areas that the formation of 
intrascrotal nodules following treatment with antifilarial drugs (or 
spontaneously) expresses the death of adult worms. Thus, the finding of 
these nodules, together with other information, may be taken to be an 
indirect sign of previous filarial infection. This may be useful in relation 
to monitoring the macrofilaricidal effect of drugs5,16,23. In this case series, 
the presence of nodules was detected in three patients, of whom two had 
made use of DEC.
Chronic filarial manifestations cannot be cured, but their spread and 
future cases can be prevented through delivery of drug combinations to 
populations where the disease is prevalent. The treatment for this morbid 
condition is based on conservative measures that avoid its progression. 
These measures consist of local hygiene care, in the same way as 
proposed for lymphedema in the limbs, and antibiotic prophylaxis using 
benzathine penicillin3. However, in some cases, surgical reconstruction 
has been shown to be efficient11, considering that this chronic disease is 
of irreversible nature.
Urogenital surgery is considered by WHO to be a critical point 
in controlling filarial morbidity, with the aim of minimizing the 
incapacitation produced by the effects of this disease in man11. Among 
the urogenital surgical approaches, surgery for hydrocele has been 
the key point within control programs for this morbid condition, and 
surgical guidelines are available from WHO for endemic filariasis areas32. 
However, lymph scrotum and other urogenital manifestations such as 
scrotal elephantiasis and chyluria have received less attention from the 
global program for eradication of lymphatic filariasis2. 
Knowledge of the profile of lymph scrotum patients highlights the 
importance of adequate surgical approaches towards hydrocele cases 
in endemic areas, with the aim of eliminating a possible risk factor for 
the appearance of this condition. It also highlights the importance of 
appropriate surgical and clinical management of this morbid condition. 
The need for laboratory investigation and specific treatment is emphasized 
in this management, with the aim of impeding progression within the 
clinical evolution of the disease and breaking the transmission chain, 
since even patients with the morbid condition may present microfilaremia. 
Furthermore, the importance of knowing these patients’ profile is 
emphasized with regard to discussing the viability of reparative surgical 
approaches for the condition of lymph scrotum. 
There is no consensus on the management methods for different 
urogenital manifestations. There is an urgent need to develop such a 
consensus, by means of reviews and expert group discussions25. The 
points made here have had the aim of contributing towards improving 
the filariasis control actions, in accordance with the guidelines of the 
global program for elimination of lymphatic filariasis.
RESUMO
Linfoescroto: apresentação rara de filaríase linfática. Estudo 
retrospectivo
A filariose linfática (FL) é responsável por uma grande variedade de 
sinais e sintomas clínicos incluindo manifestações urogenitais. O controle 
da transmissão e da incapacitação bem como o manuseio da morbidade 
são os dois pilares da estratégia global de eliminação da FL. O linfoescroto 
é uma rara apresentação da FL, tendo importantes repercussões do ponto 
de vista clínico, psicológico e socioeconômico. Realizou-se um estudo 
retrospectivo de uma série de casos com diagnóstico de linfoescroto, 
identificados entre os 6.361 pacientes ambulatoriais atendidos no 
período de 2000 a 2007 no Serviço de Referência Nacional em Filarioses 
(Recife, Brasil) área endêmica de filariose. Foram identificados sete 
casos, com a idade média de 45 anos (com variação de 26 a 64 anos). 
O tempo médio de evolução da doença foi de 8,5 anos (com variação 
de 2 a 15 anos). Todos apresentavam evidência de infecção filarial por 
algum dos exames realizados (parasitológico, pesquisa antigênica ou 
“sinal da dança da filaria” na ultrasonografia). Seis pacientes relatavam 
historia prévia de cirurgia urológica. Os autores destacam a importância 
da associação da infecção filarial e de inadequado manuseio cirúrgico e 
de acompanhamento de pacientes com hidrocele de uma área endêmica, 
como fatores de risco para o surgimento de linfoescroto. Assim, a infecção 
filarial deve ser rotineiramente investigada em todos os indivíduos 
procedentes de áreas endêmicas apresentando morbidade urológica, para 
identificar melhor os elementos da cadeia de transmissão.
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